Adis Journals
Browse
Summary Slide.png (100.51 kB)
Download file

Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina

Download (100.51 kB)
figure
posted on 2021-03-10, 17:20 authored by Adis journals on behalf of, Victoria Wurcel, Diana Chirovsky, Rebekah Borse, Juan Ignacio Altuna, Fernando Carabajal, Jyotika Gandhi

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Advances in TherapyAdvances in Therapy

    Categories

    Keywords

    ArgentinaCetuximabCost-effectivenessHead and neck squamous cell carcinomaLatin AmericaPembrolizumab

    Licence

    CC BY-NC 4.0

    Exports